Acquired disorders of platelet function

Area of Science:

• Hematology
• Internal Medicine
• Pharmacology

Background:

• Platelet dysfunction is frequently acquired, stemming from diverse factors like medications, medical procedures, and underlying hematologic conditions.
• While many substances exhibit in vitro platelet-inhibitory effects, their clinical impact on bleeding risk is often not well-defined.
• Platelet-inhibitory medications are crucial for managing vascular diseases, necessitating careful consideration to mitigate hemorrhagic risks.

Purpose of the Study:

• To review the causes of acquired platelet dysfunction.
• To discuss the clinical implications and management of bleeding risks associated with platelet dysfunction.
• To provide recommendations for optimizing patient care in the context of acquired platelet dysfunction.

Main Methods:

• Literature review of studies on acquired platelet dysfunction.
• Analysis of data concerning medications, medical conditions, and hematologic disorders affecting platelet function.
• Synthesis of information to formulate clinical recommendations.

Main Results:

• Acquired platelet dysfunction arises from various sources, including medications, cardiopulmonary bypass, renal failure, and hematologic disorders like myeloproliferative disorders and immune thrombocytopenia.
• Effective management of conditions like renal failure and the use of erythropoietin have improved bleeding outcomes, though challenges persist.
• Platelet dysfunction is associated with cardiac valvular disease, cardiopulmonary bypass, and extracorporeal membrane oxygenation, requiring specific management strategies.

Conclusions:

• Understanding the factors contributing to acquired platelet dysfunction is vital for patient care.
• Appropriate management of medications and underlying conditions can help prevent hemorrhagic complications.
• Further research is needed to clarify the clinical effects of many platelet-inhibitory agents and optimize treatment strategies.